Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Man

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
The European Respiratory Journal|March 7, 2015
Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertensionEmmy Manders, Gerrina Ruiter, Harm-Jan Bogaard, et al.
The European Respiratory Journal|July 2, 2026
Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertensionLucas R Celant, Jeroen N Wessels, J Tim Marcus, et al.
The European Respiratory Journal|August 2, 2013
Reversibility of the monocrotaline pulmonary hypertension rat modelGerrina Ruiter, Frances S de Man, Ingrid Schalij, et al.
Chest|August 1, 2023
Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial HypertensionLucas R Celant, Jeroen N Wessels, J Tim Marcus, et al.
Frontiers in Cardiovascular Medicine|January 1, 2024
Effects of empagliflozin on right ventricular adaptation to pressure overloadJulie S Axelsen, Anders H Nielsen-Kudsk, Janne Schwab, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 26, 2016
Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in ratsMichiel Alexander de Raaf, Franziska Elena Herrmann, Ingrid Schalij, et al.
Cardiovascular Diagnosis and Therapy|November 23, 2020
Mechanics of right ventricular dysfunction in pulmonary arterial hypertension and heart failure with preserved ejection fractionRoberto J Bernardo, Francois Haddad, Etienne J Couture, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 18, 2025
Long-term hemodynamic responses and reverse remodeling after pharmacotherapy in HFpEF versus HFrEF: a systematic review and meta-analysisArno A van de Bovenkamp, Soufiane Nassiri, Adrianus J Bakermans, et al.
Heart (British Cardiac Society)|August 1, 2023
Restoration of right ventricular function in the treatment of pulmonary arterial hypertensionLucas R Celant, Jeroen N Wessels, Azar Kianzad, et al.
Vascular Pharmacology|January 23, 2025
The lncRNA DSCR9 is modulated in pulmonary arterial hypertension endothelial cell models and is associated with alterations in the nitric oxide pathwayN Bernardi, B F Neep, S Garibaldi, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
The European Respiratory Journal|March 7, 2015
Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertensionEmmy Manders, Gerrina Ruiter, Harm-Jan Bogaard, et al.
The European Respiratory Journal|July 2, 2026
Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertensionLucas R Celant, Jeroen N Wessels, J Tim Marcus, et al.
The European Respiratory Journal|August 2, 2013
Reversibility of the monocrotaline pulmonary hypertension rat modelGerrina Ruiter, Frances S de Man, Ingrid Schalij, et al.
Chest|August 1, 2023
Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial HypertensionLucas R Celant, Jeroen N Wessels, J Tim Marcus, et al.
Frontiers in Cardiovascular Medicine|January 1, 2024
Effects of empagliflozin on right ventricular adaptation to pressure overloadJulie S Axelsen, Anders H Nielsen-Kudsk, Janne Schwab, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 26, 2016
Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in ratsMichiel Alexander de Raaf, Franziska Elena Herrmann, Ingrid Schalij, et al.
Cardiovascular Diagnosis and Therapy|November 23, 2020
Mechanics of right ventricular dysfunction in pulmonary arterial hypertension and heart failure with preserved ejection fractionRoberto J Bernardo, Francois Haddad, Etienne J Couture, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 18, 2025
Long-term hemodynamic responses and reverse remodeling after pharmacotherapy in HFpEF versus HFrEF: a systematic review and meta-analysisArno A van de Bovenkamp, Soufiane Nassiri, Adrianus J Bakermans, et al.
Heart (British Cardiac Society)|August 1, 2023
Restoration of right ventricular function in the treatment of pulmonary arterial hypertensionLucas R Celant, Jeroen N Wessels, Azar Kianzad, et al.
Vascular Pharmacology|January 23, 2025
The lncRNA DSCR9 is modulated in pulmonary arterial hypertension endothelial cell models and is associated with alterations in the nitric oxide pathwayN Bernardi, B F Neep, S Garibaldi, et al.
Pageof 16